SGT-507 is a relatively new synthetic cannabinoid receptor agonist, similar to compounds like MDMB-BUTINACA in its mechanism of action. These substances mimic the effects of THC by activating the cannabinoid receptors in the brain, but they often do so with far greater potency, which can lead to intense and dangerous effects.
Potency-wise, SGT-507 is reported to have a very strong affinity for the CB1 receptor, making it highly intoxicating even at low doses. While specific comparative potency data is not readily available, user reports suggest it is quite potent, potentially similar to other high-efficacy cannabinoid agonists like MDMB-BUTINACA. MDMB-BUTINACA itself is an extremely potent synthetic cannabinoid with high efficacy at the CB1 receptor, leading to powerful psychoactive effects and high risks of overdose, including fatal incidents in some cases.